Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
FDA Drug Approval Summary: Panitumumab (Vectibix™)
HTML
Details
Locations
Year:
2007
Type:
article
Source:
The Oncologist
DOI:
10.1634/theoncologist.12-5-577
Authors:
Ruthann M. Giusti,
Kaushikkumar A. Shastri,
Martin H. Cohen,
Patricia Keegan,
Richard Pazdur
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Language:
English
Topic:
Colorectal Cancer Treatments and Studies
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
panitumumab,
metastatic colorectal cancer,
EGFR inhibition,
anti-EGFR monoclonal antibody,
progression-free survival,
best supportive care,
drug approval,
adverse events,
rash,
hypomagnesemia,
paronychia,
irinotecan,
oxaliplatin,
fluoropyrimidine chemotherapy
show all 14
SDG:
Good health and well-being
Open Access status:
closed
Funder:
U.S. Food and Drug Administration
OpenAlex ID:
W2065849320
FWCI:
11.47
Cites:
12
Cited by:
239
Related to:
9